[Autologous peripheral blood stem cell transplantation for treating primary central nervous system lymphoma: a single-center retrospective study]

Rinsho Ketsueki. 2018;59(1):33-39. doi: 10.11406/rinketsu.59.33.
[Article in Japanese]

Abstract

Primary central nervous system lymphoma (PCNSL) is more difficult to treat than other lymphomas. Recently, it has been suggested that high-dose chemotherapy followed by autologous stem cell transplantation (ASCT) is effective for treating PCNSL. In the present study, we retrospectively analyzed 12 patients with PCNSL at our hospital. Five young patients with good performance status (PS) received upfront ASCT. The conditioning regimen prior to ASCT with busulfan + cyclophosphamide + etoposide showed good prognosis (complete remission rate of 100%). In addition, the PS improved in patients treated with high-dose chemotherapy followed by ASCT, while it worsened in those treated without ASCT. Further investigations are needed to clarify inclusion/exclusion criteria and optimize conditioning regimens for ASCT.

Keywords: Autologous stem cell transplantation; Conditioning regimen; Performance status; Primary central nervous system lymphoma.

MeSH terms

  • Adult
  • Aged
  • Central Nervous System Neoplasms / therapy*
  • Female
  • Humans
  • Lymphoma / therapy*
  • Male
  • Middle Aged
  • Peripheral Blood Stem Cell Transplantation*
  • Retrospective Studies
  • Transplantation, Autologous
  • Treatment Outcome